134 related articles for article (PubMed ID: 17343293)
1. Markers of inflammation and cognitive decline in an African-Caribbean population.
Jordanova V; Stewart R; Davies E; Sherwood R; Prince M
Int J Geriatr Psychiatry; 2007 Oct; 22(10):966-73. PubMed ID: 17343293
[TBL] [Abstract][Full Text] [Related]
2. Age, vascular risk, and cognitive decline in an older, British, African-Caribbean population.
Stewart R; Prince M; Mann A
J Am Geriatr Soc; 2003 Nov; 51(11):1547-53. PubMed ID: 14687383
[TBL] [Abstract][Full Text] [Related]
3. Vascular risk and cognitive impairment in an older, British, African-Caribbean population.
Stewart R; Richards M; Brayne C; Mann A
J Am Geriatr Soc; 2001 Mar; 49(3):263-9. PubMed ID: 11300236
[TBL] [Abstract][Full Text] [Related]
4. Plasma homocysteine and cognitive impairment in an older British African-Caribbean population.
Stewart R; Asonganyi B; Sherwood R
J Am Geriatr Soc; 2002 Jul; 50(7):1227-32. PubMed ID: 12133017
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory markers and cognition in well-functioning African-American and white elders.
Yaffe K; Lindquist K; Penninx BW; Simonsick EM; Pahor M; Kritchevsky S; Launer L; Kuller L; Rubin S; Harris T
Neurology; 2003 Jul; 61(1):76-80. PubMed ID: 12847160
[TBL] [Abstract][Full Text] [Related]
6. Leg length, cognitive impairment and cognitive decline in an African-Caribbean population.
Mak Z; Kim JM; Stewart R
Int J Geriatr Psychiatry; 2006 Mar; 21(3):266-72. PubMed ID: 16477589
[TBL] [Abstract][Full Text] [Related]
7. Increased plasma concentrations of serum amyloid A: an indicator of the acute-phase response after cardiopulmonary bypass.
Berendes E; Möllhoff T; Aken HV; Erren M; Deng MC; Loick HM
Crit Care Med; 1997 Sep; 25(9):1527-33. PubMed ID: 9295827
[TBL] [Abstract][Full Text] [Related]
8. Cognitive function in UK community-dwelling African Caribbean elders: normative data for a test battery.
Stewart R; Richards M; Brayne C; Mann A
Int J Geriatr Psychiatry; 2001 May; 16(5):518-27. PubMed ID: 11376469
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory markers and in-hospital mortality in acute ischaemic stroke.
Rallidis LS; Vikelis M; Panagiotakos DB; Rizos I; Zolindaki MG; Kaliva K; Kremastinos DT
Atherosclerosis; 2006 Nov; 189(1):193-7. PubMed ID: 16388807
[TBL] [Abstract][Full Text] [Related]
10. Serum inflammatory proteins and cognitive decline in older persons.
Dik MG; Jonker C; Hack CE; Smit JH; Comijs HC; Eikelenboom P
Neurology; 2005 Apr; 64(8):1371-7. PubMed ID: 15851726
[TBL] [Abstract][Full Text] [Related]
11. Long- and short-term association of low-grade systemic inflammation with cardiovascular mortality in the LURIC study.
Kälsch AI; Scharnagl H; Kleber ME; Windpassinger C; Sattler W; Leipe J; Krämer BK; März W; Malle E
Clin Res Cardiol; 2020 Mar; 109(3):358-373. PubMed ID: 31263995
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory markers and cognitive function in middle-aged adults: the Whitehall II study.
Gimeno D; Marmot MG; Singh-Manoux A
Psychoneuroendocrinology; 2008 Nov; 33(10):1322-34. PubMed ID: 18774232
[TBL] [Abstract][Full Text] [Related]
13. [Variations of serum amyloid A protein and interleukin-6 in patients with low concentration of serum C-reactive protein].
Shimetani N; Ichikawa K; Hachimura K; Tanaka T; Ohtani S; Kanoh Y; Ohtani H
Rinsho Byori; 1996 Jul; 44(7):669-75. PubMed ID: 8741497
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-6 and C-Reactive Protein Levels and 9-Year Cognitive Decline in Community-Dwelling Older Women: The Women's Health and Aging Study II.
Palta P; Xue QL; Deal JA; Fried LP; Walston JD; Carlson MC
J Gerontol A Biol Sci Med Sci; 2015 Jul; 70(7):873-8. PubMed ID: 25161214
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-6 and C-reactive protein as predictors of cognitive decline in late midlife.
Singh-Manoux A; Dugravot A; Brunner E; Kumari M; Shipley M; Elbaz A; Kivimaki M
Neurology; 2014 Aug; 83(6):486-93. PubMed ID: 24991031
[TBL] [Abstract][Full Text] [Related]
16. Interleukin 6 plasma concentration associates with cognitive decline: the northern Manhattan study.
Economos A; Wright CB; Moon YP; Rundek T; Rabbani L; Paik MC; Sacco RL; Elkind MS
Neuroepidemiology; 2013; 40(4):253-9. PubMed ID: 23364322
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers of inflammation are associated with colorectal cancer risk in women but are not suitable as early detection markers.
Toriola AT; Cheng TY; Neuhouser ML; Wener MH; Zheng Y; Brown E; Miller JW; Song X; Beresford SA; Gunter MJ; Caudill MA; Ulrich CM
Int J Cancer; 2013 Jun; 132(11):2648-58. PubMed ID: 23161620
[TBL] [Abstract][Full Text] [Related]
18. Association between raised inflammatory markers and cognitive decline in elderly people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study.
Marioni RE; Strachan MW; Reynolds RM; Lowe GD; Mitchell RJ; Fowkes FG; Frier BM; Lee AJ; Butcher I; Rumley A; Murray GD; Deary IJ; Price JF
Diabetes; 2010 Mar; 59(3):710-3. PubMed ID: 19959761
[TBL] [Abstract][Full Text] [Related]
19. C-reactive protein and genetic variants and cognitive decline in old age: the PROSPER study.
Mooijaart SP; Sattar N; Trompet S; Polisecki E; de Craen AJ; Schaefer EJ; Jahn SE; van Himbergen T; Welsh P; Ford I; Stott DJ; Westendorp RG;
PLoS One; 2011; 6(9):e23890. PubMed ID: 21915265
[TBL] [Abstract][Full Text] [Related]
20. Peripheral levels of fibrinogen, C-reactive protein, and plasma viscosity predict future cognitive decline in individuals without dementia.
Marioni RE; Stewart MC; Murray GD; Deary IJ; Fowkes FG; Lowe GD; Rumley A; Price JF
Psychosom Med; 2009 Oct; 71(8):901-6. PubMed ID: 19661193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
